Research Article

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms

Table 3

Inflammation signaling related gene expression in CD34+ cells of MPNs.

GenesControlETPVPMF
MeanSDMeanSDMeanSDMeanSD

IL-6 signaling pathway related gene expression
CEBPB CCAAT/enhancer binding protein β−0.30.48−0.50.63−0.30.49−0.10.54
FOS FBJ murine osteosarcoma viral oncogene homolog2.460.873.111.043.740.952.351.38
MAP2K1Mitogen-activated protein kinase kinase 10.490.310.70.151.060.260.190.52
RAF1 v-raf-1 murine leukemia viral oncogene homolog 11.660.292.020.272.110.341.950.38
SHC1 Src homology 2 domain cont transforming protein 1−0.70−0.30.540.270.04−1.10
CSNK2A1Casein kinase 2, α 1 polypeptide0.230.060.230.050.350.510.480.52

NF-B signaling pathway related gene expression
TNFRSF1ATumor necrosis factor receptor superfamily, member 1A 0.580.721.260.861.540.421.640.40
NFKBIA Nuclear factor of kappa light polypept gene enhancer in B-cells inhibitor, α4.240.823.701.023.570.912.821.06
TRADD TNFRSF1A-associat via death domain 1.300.421.670.221.790.311.380.32
NFKB1 Nuclear factor of kappa light polypept gene enhancer in B-cells 10.690.170.281.131.170.241.341.16

TGF-beta signaling pathway related gene expression
CDKN2B Cyclin-dependent kinase inhibitor 2B0.641.05−0.11.15−0.71.11−1.21.14
ID3 Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein−2.10.48−2.40.65−3.10.14−3.10.37
TFDP1 Transcription factor Dp-1 −0.10.490.110.40.610.40.960.69
BMPR2 Bone morphogenetic prot rec type II 1.9901.020.892.010.16
TGFBR1 Transforming growth factor, β recep 1 0.590.351.040.50.660.14
TGFBR2 Transforming growth factor, β recep II 1.670.181.550.291.610

IL-10 signaling pathway related gene expression
BLVRA Biliverdin reductase A0.700.591.130.451.500.401.310.29
IL10RB Interleukin 10 receptor0.960.311.300.701.150.730.830.75
HMOX1 Heme oxygenase (decycling) 11.300.442.410.442.320.59

Bolded genes represent significantly changed expression versus controls ().